Carcinoma
3 competing products in clinical development for Carcinoma.
Pipeline by Phase
Phase 12
Phase 21
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| NRC-2694-A + Paclitaxel | Natco Pharma | Phase 2 | Recruiting | 42 |
| AGS-8M4 | Astellas Pharma | Phase 1 | Completed | 29 |
| AGS-8M4 + Pegylated liposomal doxorubicin (PLD) + gemcitabine + carboplatin | Astellas Pharma | Phase 1 | Terminated | 21 |